Prostate News Archive
03-May-2008
Biomarker predicts prostate risk factor (UPI)
BARCELONA, Spain, May 2 (UPI) -- Spanish researchers found how to distinguish between cancerous and benign high-grade prostatic intraepithelial neoplasia, a prostate cancer risk factor. Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer (HealthCentral.com)
Copyright © 2008 ScoutNews LLC. All rights reserved. FRIDAY, May 2 (HealthDay News) -- Spanish researchers report they may have found a way to tell which suspicious prostate lesions are likely to develop into cancer. A Mini-Protein Found In Sunflower Seeds Could Be The Key To Stopping Tumors Spreading In Prostate Cancer Patients, ... (Medical News Today)
Flower power may bring ray of sunshine to cancer sufferersThe grants came from Queensland Cancer Research, the Prostate Cancer Foundation, and the National Health and Medical Research Council."We are interested in this miniprotein as a potential treatment of prostate cancer, in particular for those patients who relapse," said Dr Harris. Malignancy Potential Of HG-PIN Lesions In The Prostate Predicted By Biomarker (Medical News Today)
Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, "stuck" between diagnoses - they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution. Prostate Cancer Startup CivaTech Oncology Reaches Funding Goal (InfoBolsa)
29/04/2008 17:43:00 Business Wire CivaTech Oncology, Inc., an early stage company developing a novel medical device for the treatment of prostate cancer, has raised $1,000,000 in a Series B private financing round.
Back to Prostate News Archive
